MAP1LC3A and Parkinson disease: Furthermore, a potential therapy for neurodegenerative disorder diseases including Parkinson’s disease (PD) was reported for compound 5 that was identified to induce autophagy in GFP-LC3 stable HeLa cell at 10 μM.